Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P K Leichner

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 1, 1991
Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinomaG B Stillwagon, S E Order, T Haulk, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Selection of reagents for human radioimmunotherapyH M Vriesendorp, S M Quadri, R L Stinson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1982
Multimodality treatment of patients with advanced ovarian carcinomaJ L Pino y Torres, D S Bross, E Hernandez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1995
SPECT imaging of fluorine-18P K Leichner, H T Morgan, K P Holdeman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49P K Leichner, G Akabani, D Colcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's diseaseP J Bierman, J M Vose, P K Leichner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group studyS E Order, G B Stillwagon, J L Klein, et al.
Journal of Computer Assisted Tomography|July 1, 1986
CT volumetrics of primary liver cancersN C Yang, P K Leichner, E K Fishman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1987
Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group StudyG B Stillwagon, S E Order, J L Klein, et al.
Cancer Research|November 15, 1989
Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatomaJ L Klein, T H Nguyen, P Laroque, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|November 1, 1991
Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinomaG B Stillwagon, S E Order, T Haulk, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Selection of reagents for human radioimmunotherapyH M Vriesendorp, S M Quadri, R L Stinson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1982
Multimodality treatment of patients with advanced ovarian carcinomaJ L Pino y Torres, D S Bross, E Hernandez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1995
SPECT imaging of fluorine-18P K Leichner, H T Morgan, K P Holdeman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49P K Leichner, G Akabani, D Colcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's diseaseP J Bierman, J M Vose, P K Leichner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group studyS E Order, G B Stillwagon, J L Klein, et al.
Journal of Computer Assisted Tomography|July 1, 1986
CT volumetrics of primary liver cancersN C Yang, P K Leichner, E K Fishman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1987
Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group StudyG B Stillwagon, S E Order, J L Klein, et al.
Cancer Research|November 15, 1989
Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatomaJ L Klein, T H Nguyen, P Laroque, et al.
Pageof 6